Posts

Showing posts with the label Connected Drug Delivery Devices Market Share

Connected Drug Delivery Devices Market Expected To Grow With USD 4.07 Billion By 2028

  San Francisco, 24 March 2021:   The Report  Connected Drug Delivery Devices Market  Size, Share & Trends Analysis Report By Technology (Bluetooth, NFC), By Product (Connected Sensors, Integrated Connected Devices), By End User, And Segment Forecasts, 2021 - 2028 The global connected drug delivery devices market size is expected to reach USD 4.07 billion by 2028 registering a CAGR of 46.7%, according to a new report by Grand View Research, Inc. Factors contributing to the growth of this market include a rise in awareness about the adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. The Covid-19 pandemic has further accentuated the need for “contactless” services, thereby increasing the demand for connected drug delivery devices as well as providing lucrative growth opportunities in the coming years. Connected drug delivery devices help physicians to monitor the compliance of patients to the therapy prescribed by them

Connected Drug Delivery Devices Market Expected To Witness Lucrative Growth At CAGR Of 25.1% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 4 July 2019:  The Report  Connected Drug Delivery Devices Market  Analysis Report By Technology (Bluetooth, NFC), By Product (Connected Sensors, Integrated Connected Devices), By End User, And Segment Forecasts, 2018 – 2025 The global connected drug delivery devices market size is expected to reach USD 717.7 million by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a strong CAGR of 25.1% during the forecast period. Factors contributing to the growth of this market include rise in awareness regarding adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. Based on the product type, connected drug delivery systems are categorized as sensors and integrated devices. The sensors segment accounted for the largest market share of 72.6% in 2017. The connected sensors are cost-effective as compared to their integrated counterparts. Moreover, the cost of switching fr